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Bartonella henselae is a gram-negative facultative intracellular bacterium and is the
causative agent of cat-scratch disease. Our previous data have established that
Bacteroides fragilis colonization is able to prevent B. henselae damages through the
polysaccharide A (PSA) in an experimental murine model. In order to determine whether
the PSA is essential for the protection against pathogenic effects of B. henselae in
immunocompromised hosts, SCID mice were co-infected with B. fragilis wild type or
its mutant B. fragilis 1PSA and the effects of infection on murine tissues have been
observed by High-Frequency Ultrasound (HFUS), histopathological examination, and
Transmission Electron Microscopy (TEM). For the first time, echostructure, hepatic lobes
length, vascular alterations, and indirect signs of hepatic dysfunctions, routinely used as
signs of disease in humans, have been analyzed in an immunocompromised murine
model. Our findings showed echostructural alterations in all infected mice compared
with the Phosphate Buffer Solution (PBS) control group; further, those infected with
B. henselae and co-infected with B. henselae/B. fragilis 1PSA presented the major
echostructural alterations. Half of the mice infected with B. henselae and all those co-
infected with B. henselae/B. fragilis 1PSA have showed an altered hepatic echogenicity
compared with the renal cortex. The echogenicity score of co-infected mice with
B. henselae/B. fragilis 1PSA differed significantly compared with the PBS control group
(p < 0.05). Moreover the inflammation score of the histopathological evaluation was
fairly concordant with ultrasound findings. Ultrastructural analysis performed by TEM
revealed no significant alterations in liver samples of SCID mice infected with B. fragilis
wild type while those infected with B. fragilis 1PSA showed the presence of collagen
around the main vessels compared with the PBS control group. The liver samples of
mice infected with B. henselae showed macro-areas rich in collagen, stellate cells, and
histiocytic cells. Interestingly, our data demonstrated that immunocompromised SCID
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mice infected with B. henselae and co-infected with B. henselae/B. fragilis 1PSA
showed the most severe morpho-structural liver damage. In addition, these results
suggests that the HFUS together with histopathological evaluation could be considered
good imaging approach to evaluate hepatic alterations.
Keywords: Bartonella henselae, Bacteroides fragilis, PSA, SCID mice, HFUS, Histological examination, Imaging,
TEM
INTRODUCTION
Bartonella henselae, a facultative intracellular gram-negative
bacterium, causes cat-scratch disease, a self-limiting infection
often characterized by lymphadenopathy or by an asymptomatic
course in immunocompetent patients (Eicher and Dehio, 2012;
Harms and Dehio, 2012). Otherwise, B. henselae infections occur
more frequently in immunocompromised patients (Maguiña
et al., 2009) that may develop bacillary angiomatosis (BA)
or peliosis (BP), vasoproliferative tumor lesions of the skin
or the inner organs (Mosepele et al., 2012). Intraerythrocytic
and endothelial persistence of Bartonella are distinguishing
features in immunocompetent and immunocompromised
hosts (Mosepele et al., 2012). Bartonella infections in the
immunocompromised host may be characterized by fever,
osteomyelitis, or angioproliferative lesions that may affect
virtually any organ system, but have a predilection for highly
vascularized tissues such a heart valves, liver, and spleen
(Maguiña et al., 2009; Mosepele et al., 2012). A murine model
of chronic infection in immunocompromised SCID/Beige
mice showed the ability of Bartonella to recapitulate human
pathologies; indeed, in this model, bacteria grow in extracellular
aggregates, embedded within collagen matrix similar to the
observations in BA, BP, and catch-scratch disease (Chiaraviglio
et al., 2010). In addition, B. henselae can infect and damage
endothelial progenitors cells (EPCs) reducing the endothelium
regenerating potential (Salvatore et al., 2008, 2015; Costa et al.,
2010).
Bacteroides fragilis is a gram-negative anaerobe bacterium
belonging to the gut microflora (Coyne and Comstock, 2008). It
protects mice from experimental colitis induced by Helicobacter
hepaticus through the polysaccharide A (PSA; Mazmanian et al.,
2008; Troy and Kasper, 2010). B. fragilis, via the PSA, can exert
its effect through the immune system within both the intestinal
and the systemic compartments (Mazmanian et al., 2008; Ochoa-
Repàraz et al., 2010; Heijtz et al., 2011).
In a previous study, we have established that the damage
induced by B. henselae in liver and aorta of immunocompetent
mice could be prevented with B. fragilis wild type co-infection
but not with its mutant B. fragilis 1PSA (Pagliuca et al., 2012).
Our earlier data showed that the prevention of damages caused
by B. henselae was mediated by PSA, and B. fragilis competed with
B. henselae during internalization of EPCs (Pagliuca et al., 2012).
In order to investigate whether B. fragilis can ameliorate
inflammatory disease caused by B. henselae in an
immunocompromised SCID mouse model we evaluated
the effect on tissues of co-infected mice with B. henselae and
B. fragilis wild type or B. fragilis1PSA by in vivo High-Frequency
Ultrasound (HFUS) and ex vivo histological and Transmission
Electron Microscopy (TEM) examinations. Interestingly, the
scores of hepatic HFUS and histological evaluation of murine
liver tissues belonging to differently infected and co-infected
mice showed a substantial correlation. To the best of our
knowledge this report represents the first study in a murine
model of bacterial infection in which was showed the correlation
between ultrasonographic and histopathological findings, but
still these two techniques should be considered complementary
to gain a precise diagnosis on the hepatic alterations induced by
bacterial infection. In addition this is the first attempt of studying
the hepatic alterations due to B. henselae infection and the
consequent inflammation and fibrosis in immunocompromised
mice with in vivo HFUS.
MATERIALS AND METHODS
Bacterial Strains and Growth Conditions
Bartonella henselae strain ATCC49882 (LGC Promochem) was
stored at −80◦C in Tryptone Soya Broth USP (TSB; Oxoid)
with 10% (vol/vol) glycerol (Carlo Erba) until use, and grown
on Trypticase Soy Agar (TSA) with 5% sheep blood (Becton
Dickinson, BD) in a humidified atmosphere at 37◦C and 5%
CO2 for 7 days. B. fragilis NCTC9343 wild type and its mutant
B. fragilis1PSA were kindly provided by Prof. Dennis L. Kasper.
The strains were stored at −80◦C in Brain Heart Infusion
Broth (Oxoid) with 10% (vol/vol) glycerol until use, and grown
anaerobically onto BD Schaedler agar with 5% sheep blood at
37◦C for 48 h.
Murine Strain and Infection
Specific pathogens free C.B-17/IcrHsd-PrkdcSCID (SCID) female
mice 8 weeks of age, with severe combined immunodeficiency
affecting T and B cell development, were purchased from Harlan
Laboratories (Correzzana, Milano, Italy). The mice were fed with
laboratory food pellets and tap water ad libitum and were bred
and housed under specific pathogen free conditions at Ceinge-
Advanced Biotechnologies, Naples, Italy. B. fragilis wild type
or B. fragilis 1PSA was given to animals (n = 6/group) in
concentration 109 CFU in 0.1 ml of Phosphate Buffer Solution
(PBS) 1% per mouse by oral administration. Viable counts
were performed on BD Schaedler agar with 5% sheep blood
to determine the number of CFU. Mouse enteric colonization
was initiated 7 days prior to B. henselae infection and the
bacterial suspension was given as previously described (Pagliuca
et al., 2012). Prior to infection, B. henselae was thawed at
room temperature, harvested by centrifugation for 15 min at
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1,500 rpm, and re-suspended in PBS 1%. Mice were infected
with B. henselae via intra-peritoneal route at a dose of 109
CFU/mouse. Control mice were injected with PBS 1% in
the absence of bacteria. Viable counts were performed on
TSA plates with 5% sheep blood to determine the number
of CFU. Following infection, SCID mice were observed once
a day for signs of illness. Every day throughout the whole
experiment, animals were monitored for clinical symptoms
(i.e., ruﬄed fur, weight loss, lethargy, or moribund). Body
weight was measured by using a digital balance (Gibertini).
Whenever mice showed weight loss of 30% from baseline
value, euthanasia would have been applied. Since no animals
showed signs of stress, no weight loss, analgesics were never
given and euthanasia was used only at the end of experiment
(36 days). Between 30 and 31 days post-infection, the mice
were analyzed by HFUS under general anesthesia. At the times
of euthanasia, animals were anesthetized (50 mg/kg ketamine
and 3 mg/kg xylazine) and were humanely killed by cervical
dislocation. Liver, spleen, and aorta were excised and fixed
for histological and microscopic analysis. Previous observations
suggested that established endpoint was able to detect tissue
damage induced by B. henselae both in immunocompetent and
immunocompromised murine host (Chiaraviglio et al., 2010;
Pagliuca et al., 2012).
Ethics Statement
All animal experiments were carried out according to
institutional guidelines. All efforts were made to minimize
animal suffering and to reduce the number of mice used, in
accordance with the European Communities Council Directive
of November 24, 1986 (86/609/EEC). The protocol of the study
has been reviewed and approved by Ethical Animal Care and Use
Committee of Ceinge-Advanced Biotechnologies, Naples, Italy,
Prot n◦ 2, del 14/12/2012.
High Frequency Ultrasound Evaluation
A total of 36 SCID mice were examined over the course of the
study. All procedures were performed under general anesthesia
with 4% isoflurane (induction dose) and 2% isoflurane plus
oxygen (2 Lt/min; maintenance dose). Body temperature was
monitored using a rectal probe and maintained in a physiological
range using an infrared lamp. Hair coat on the abdominal region
was removed by shaving followed by a hair remover cream, and
an ultrasound-coupling gel was applied to the skin to improve
ultrasound transmission and reduce contact artifacts. Mice were
imaged using a transducer with a central frequency of 40 MHz
(focal length 6 mm; depth of penetration ranging from 5 to
15 mm; 30–40 µm axial and 70–90 µm lateral resolution)
mounted on an ultrasound system (Vevo 2100, FUJIFILM
VisualSonics, Inc., Toronto, ON, Canada).
The animals were positioned in dorsal recumbency and
liver images were obtained in cross-sectional two-dimensional
(B-mode) imaging modality in transversal and longitudinal
planes. Ultrasonographic findings were analyzed according to the
following classification (Lessa et al., 2010; Resende et al., 2011):
(i) Echostructure – score 0: homogeneous liver parenchyma and
a regular hepatic surface; score 1: diffuse parenchymal mild
heterogeneity, reduced visualization of the diaphragm and small
peripheral vessels with no change on liver surface; score 2:
discrete coarse and heterogeneous parenchymal echostructure,
dotted or slightly irregular liver surface; score 3: extensive
coarse and heterogeneous parenchymal echostructure, irregular
or nodular hepatic surface with underlying regenerative nodules;
(ii) Echogenicity (relative to the renal cortex) – score 0: liver less
echogenic than the renal cortex; score 1: hepatic echogenicity
equal to the renal cortex; score 2: liver more echogenic than
the renal cortex; (iii) Presence of ascites – score 0: absent; score
1: present. Furthermore, right and caudate lobes length and
caudate/right lobe ratio, the spleen area and the portal vein (PV)
diameter were measured as non-invasive predictive indicator of
the development of liver disease; color-Doppler and pulse-wave
Doppler were used in combination to obtain the maximum PV
blood velocity (Aubé et al., 1999; Tchelepi et al., 2002; Lu et al.,
2003; Bonekamp et al., 2009; Resende et al., 2011).
Histological Examination
All samples were formalin-fixed and embedded in paraffin.
Serial sections, 5 µm thick were cut from each paraffin block
and a section routinely stained with hematoxylin and eosin
(H&E) for the morphological evaluation and grade inflammation.
To assess collagen fibers, paraffin sections were stained with
Masson’s Trichrome (Masson’s Trichrome AR173 Dako. Dako
Autostainer Artisan Link), Sirius Red (Sirius Red/Fast Green
FCF, Carlo Erba-Sigma Aldeich Direct Red 80), and Reticulin
(Reticulin-Nuclear Fast Red AR179 Dako. Dako Autostainer
Artisan Link). The staging of hepatic fibrosis was performed
using semi-quantitative fibrosis scores (F-scores), which is similar
to the score systems proposed by Batts and Ludwig (1995) and
Ishak et al. (1995) for hepatic fibrosis in humans. Normal liver
sections without fibrosis were classified as F0; fibrous expansion
of portal areas was scored as F1; stage F2 denotes septal fibrosis
with numerous marked fibrous septa. Other stages of Ishak was
not observed. The portal inflammation was grading: G0 (none),
G1 (mild, some or all portal areas), G2 (moderate, some or
all portal areas), G3 (moderate/marked, all portal areas), G4
(marked, all portal areas) as described in literature (Ishak et al.,
1995).
Transmission Electron Microscopy (TEM)
The liver tissues were cut into 1 mm3 blocks and fixed in 1.5%
glutaraldehyde in 0.067 M cacodylate buffer at pH 7.4 for 3 h
at 4◦C (Pagliuca et al., 2012). Then, they were post-fixed in 1%
osmium tetroxide in 0.067 M cacodylate buffer at pH 7.4 for
1 h at 4◦C and dehydrated in ascending series of ethyl alcohol
and then embedded in epon. Semi-thin sections were cut with
a glass knife and were stained with 1% toluidine blue for light
microscopic observations. Ultra-thin sections were stained with
3% uranyl acetate in 50% ethyl alcohol and with 2.6% lead citrate
and observed under a Philips EM 208 S transmission electron
microscope (Philips Company) at 100 kV.
Statistical Analysis
All tests were performed with a commercial program for
statistical analysis (JMP R© 8.0, SAS Institute Inc., Cary, NC, USA).
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All measurements described in the ultrasonographic evaluation
were compared between the infected groups and the PBS control
group with the Dunnett’s test; a group received a score of 1 if
a significant difference was detected. The partial scores of the
echostructure, echogenicity, and total scores were compared with
the PBS control group using the Dunnett’s test. Furthermore,
both scores and measurements were compared between all
groups using “each couple” Student’s t-test. The ultrasound scores
were correlated with the histological scores with the Spearman’s
rank-order correlation coefficient (rs). The limit of significance
was set at p< 0.05 (Dytham, 2011; Petrie and Watson, 2013).
RESULTS
Immunocompromised Murine Infection
Model
In order to determine whether PSA was essential for protection
against pathogenic effects induced by B. henselae, SCID mice
were inoculated with either B. fragilis wild type or its mutant
B. fragilis 1PSA. Three groups of six immunocompromised
mice were infected with 109 CFU of either B. fragilis wild type
or B. fragilis 1PSA or B. henselae, respectively (Groups 1–3),
whereas two groups of animals were co-infected with B. henselae
(109 CFU) and alternatively with B. fragilis wild type (Group
4) or B. fragilis 1PSA (109 CFU; Group 5). The control was
represented by Group 6 (Figure 1). The health of animals was
evaluated once a day for the full duration of the experiment, no
animals showed sign of suffering or illness (data not show) and
no animals died after any infection. Survival was recorded for
the whole duration of experiment. After 30 days, the animals
were analyzed by HFUS and, after 36 days, mice were euthanized
in order to assess both the bacterial infections and the role of
B. fragilis PSA by histopathology and TEM evaluation on infected
tissues.
High Frequency Ultrasound Evaluation
The morphological, functional and echostructural analysis of the
liver performed with HFUS demonstrated clearly that B. henselae
TABLE 1 | High frequency ultrasound scores of echostructure,
echogenicity, and ascites.
Group Echostructure Echogenicity Ascites Total
B. henselae 2A 0.5 0.5 3Aa
Bartonella
henselae/Bacteroides
fragilis
1.5a 0 0 1.5b
B. fragilis 1.5a 0 0 1.5b
B. fragilis1PSA
(polysaccharide A)
1.5a 0 0 1.5b
B. henselae/B.
fragilis1PSA
2A 1a 0 3Aa
Control 0Bb 0b 0 0Bc
Median value of scores assigned to echostructure, echogenicity, ascites, and the
total score. Statistical differences: A > B, p < 0.01; a > b, b > c, p = 0.01.
infected mice as well as B. henselae/B. fragilis 1PSA co-infected
mice showed most severe signs of liver disease in comparison
with those co-infected with B. henselae/B. fragilis wild type and
no infected (Table 1; Supplementary Figure S1). Nevertheless,
none of the measurement obtained with HFUS resulted to be
different between the infected and control SCID mice, nor among
the different types of infection (Supplementary Table S1).
All infected mice presented an altered echostructure, which
resulted significantly different compared with the PBS control
group (p < 0.05; Figure 2C). An example of the different
scores of hepatic echostructure are shown in Figure 2. In
particular, SCID mice infected with B. henselae and co-infected
with B. henselae/B. fragilis 1PSA presented a discrete coarse and
heterogeneous parenchymal echogenicity (Example of score 2;
Figure 2B) compared with those co-infected with B. henselae/B.
fragilis wild type that presented a diffusely increased parenchymal
echogenicity on liver surface (Example of score 1; Figure 2A).
Alteration of echogenicity was noted in the 50% of the mice
infected with B. henselae and in all B. henselae/B. fragilis1PSA
co-infected mice (Example of score 1; Figure 3A), characterized
by hepatic echogenicity equal to the renal cortex. In all other mice
the liver was less echogenic than the renal cortex (Example of
score 0; Figure 3B). The echogenicity score of co-infected mice
FIGURE 1 | Murine infection with Bartonella henselae and Bacteroides fragilis. Scheme of immunocompromised murine infection: three groups of SCID
mice (n = 6/group) were infected with B. henselae, or B. fragilis, or B. fragilis 1PSA (polysaccharide A), two groups of animals (n = 6/group) were co-infected with
B. henselae and B. fragilis or B. fragilis 1PSA, and one group were injected with Phosphate Buffer Solution (PBS) 1% in the absence of bacteria (PBS control group).
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FIGURE 2 | Analysis of hepatic echostructure of infected SCID mice. (A) Example of score 1: diffusely increased parenchymal echogenicity, reduced
visualization of the diaphragm and small peripheral vessels (circular dotted line) with no change on liver surface in SCID co-infected mice with B. henselae/B. fragilis
wild type. (B) Example of score 2: discrete coarse and heterogeneous parenchymal echogenicity (circular dotted line), dotted or slightly irregular liver surface in SCID
co-infected mice with B. henselae/B. fragilis1PSA (arrows). (C) Example of score 0: homogeneous liver parenchyma with medium level echogenicity and a regular
hepatic surface in SCID PBS control group.
FIGURE 3 | Analysis of hepatic echogenicity of infected SCID mice. In the figure are shown examples of echogenicity, relative to the renal cortex, (arrow)-on
the left of the pictures. (A) Example of score 1: hepatic echogenicity equal to the renal cortex observed in SCID co-infected mice with B. henselae/B. fragilis1PSA.
(B) Example of score 0: liver less echogenic than the renal cortex (arrow) in SCID co-infected mice with B. henselae/B. fragilis wild type. (C) Presence of ascites (on
the arrow), caval and portal dilatation (on the right of the picture) in SCID mice infected with B. henselae.
with B. henselae/B. fragilis 1PSA differed significantly compared
with the PBS control group (p < 0.05). In addition ascites, with
an accumulation of fluid in the abdominal cavity, was detected
in 50% of the mice infected with B. henselae (Figure 3C) but no
statistical difference was detected compared with the PBS control
group. The median scores of echostructure, echogenicity, ascites,
and the total scores (i.e., the sum of the scores above mentioned)
for each group are reported in Table 1. The HFUS evaluation
revealed alterations of the liver parenchyma but did not show any
pathological features in the other observed structures, including
small and large bowel (data not shown).
The median total HFUS scores were significantly higher
in mice infected with B. henselae and co-infected mice with
B. henselae/B. fragilis 1PSA compared to all other groups
(p < 0.01), whereas all other infected mice groups had a
higher score compared to PBS control mice (p = 0.01; Table 1;
Supplementary Figure S1).
Histopathological Analysis and
Correlation with HFUS Evaluation
After 36 days, animals were euthanized in order to assess both
the effect of bacterial infection and B. fragilis protection by
histopathology and TEM of infected tissues (see paragraphs
below). The median scores for hepatic phlogosis and fibrosis
obtained by histopathological evaluation are reported in Figure 4.
All infected SCID mice showed a phlogosis and fibrosis score
(Figures 5 and 6) significantly higher compared with the PBS
control group (Figures 5A–D). In particular, it was highlighted
by H&E staining an inflammation of G2 score (moderate, some
or all portal areas) in SCID mice infected with B. henselae
(Figure 5E), which resulted significantly higher compared to all
other groups (p ≤ 0.01), except for B. fragilis1PSA (Figure 4).
A moderate inflammation, of G1–G2 score, was found in animals
infected with B. fragilis1PSA (Figure 6D). Instead, a portal
inflammation of G1 score (mild, some or all portal areas)
was observed both in mice infected with B. fragilis wild type
(Figure 6F) and in both co-infected groups (Figures 6A,I). In
addition, mice infected with B. henselae and co-infected with
B. henselae/B. fragilis1PSA also had the higher fibrosis score
equal to F2 (Figures 4, 5H, and 6J), whereas all other infected
mice exhibited a fibrosis score ≤ to F1 (fibrous expansion
of portal areas; Figures 6B,C,E,G,H) compared with the PBS
control group (p< 0.05; Figures 4 and 5B–D). Histopathological
data confirmed that SCID mice infected with B. henselae showed
the highest total score (Figure 4).
The statistical analysis performed on the whole HFUS
and histopathological dataset showed a significant positive
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FIGURE 4 | Graphic representation of the median scores of the histopathological grading. (A) Bar graph represents the median inflammation score in the
different groups. (B) Bar graph represents the median fibrosis score in the different groups. Statistical differences: A > B, B > C. ∗∗∗p < 0.001, ∗∗p < 0.01,
∗p < 0.05.
FIGURE 5 | Histological analysis of liver sections in infected SCID mice with B. henselae compared with PBS control group. (A–D) Representative liver
section showing G0 (A) H&E ×10 magnification, black arrow and F0 (B) Sirius Red/Fast Green ×10 magnification, red arrow; (C) Masson’s Trichrome ×10
magnification, blue arrow; (D) Reticulin-Nuclear Fast Red ×20 magnification, brown arrow in the PBS control group. (E–H) Representative liver section showing G2
(E) H&E ×10 magnification, black arrow and F2 (F) Sirius Red/Fast Green ×10 magnification, red arrow; (G) Masson’s Trichrome ×10 magnification, blue arrow;
(H) Reticulin-Nuclear Fast Red ×20 magnification, brown arrow in the B. henselae infected group.
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FIGURE 6 | Histological analysis of liver sections in infected SCID mice with B. fragilis, B. fragilis 4PSA, and in co-infected SCID mice. (A–C)
Representative liver section showing G1 (A) H&E ×10 magnification, black arrow, and F1 (B) Masson’s Trichrome ×10 magnification, blue arrow; (C) Sirius Red/Fast
Green ×10 magnification, red arrow in the SCID co-infected mice with B. henselae/B. fragilis wild type; (D,E) Representative liver section showing G1–G2 (D) H&E
×10 magnification, black arow and F1 (E) Reticulin-Nuclear Fast Red ×20 magnification, brown arrow in the B. fragilis 4PSA infected group. (F–H) Representative
liver section showing G1 (F) H&E ×10 magnification, black arrow and F1 (G) Sirius Red/Fast Green ×10 magnification, red arrow; (H) Reticulin-Nuclear Fast Red
×20 magnification, brown arrow in the B. fragilis wild type infected group; (I,J) Representative liver section showing G1 (I) H&E ×10 magnification, black arrow and
F1–F2 (J) Reticulin-Nuclear Fast Red ×20 magnification, brown arrow in the B. henselae/B. fragilis 4PSA infected group.
correlation between the inflammation score and the
echostructure (rs = 0.63; P = 0.020), ascites (rs = 0.55;
P = 0.048), and the total scores (rs = 0.65; P = 0.017),
furthermore the fibrosis score had a significant correlation
with echostructure (rs = 0.61; P = 0.026), ascites (rs = 0.49;
P = 0.048), and total scores (rs = 0.62; P = 0.025). Considering
the mean scores for each group, the same correlations were
confirmed, and a further correlation between fibrosis and
echogenicity scores was detected (rs= 0.35; P = 0.038).
The histopathological analysis carried out on other organs
(spleen and aorta) showed no pathological alteration (data not
shown).
Ultrastructural Analysis
Ultrastructural analyses performed by TEM revealed no
significant alterations in liver samples of mice infected with
B. fragilis wild type (Figure 7B) compared with the PBS control
group (Figure 7A) except for the presence of histiocytic cells
in the sub-endothelial region of the main vessels. In samples
infected with B. fragilis1PSA the presence of collagen around the
main vessels was observed (Figure 7C). The liver samples of mice
infected with B. henselae (Figure 7D) showed macro-areas rich in
collagen, stellate cells, and histiocytic cells. Rare B. henselae were
found in collagen (Figures 8A,B). The liver samples co-infected
with B. henselae/B. fragilis wild type showed the presence of
histiocytic cells in the sub-endothelial region of the main vessels
(Figure 7E). Here, limited areas with collagen containing these
bacteria were also found (Figure 8C). In liver samples co-infected
with B. henselae/B. fragilis 1PSA, the presence of areas rich in
collagen in the sub-endothelial region of the main vessels and
adjacent to hepatocytes were observed (Figure 7F). These areas
were smaller compared with those of liver samples infected
only with B. henselae (Figure 7D). Bacterial internalization was
observed in these samples (Figure 8D). The endothelial cells
of the main vessels presented morphological alterations with
ribbon mitochondria (Figure 7G) and high amount of smooth
reticulum profiles. In all samples analyzed for each infection
type, no alterations either hepatocytes or bile ducts, or sinusoids
were found.
DISCUSSION
The results of this study have established, for the first time, that
HFUS evaluation showed the ability to identify echostructural
alterations in all infected SCID mice compared with PBS control
group. Moreover our in vivo studies indicated that half of
mice infected with B. henselae and all co-infected mice with
B. henselae/B. fragilis1PSA showed an altered echogenicity with
the hepatic echogenicity equal to the renal cortex. It is important
to underline that, by this approach, kidney diseases should
be excluded (Resende et al., 2011). Moreover, ultrasonography
allowed to confirm the presence of ascites, even when mild,
another sign of portal hypertension and diffuse liver disease
(Heller and Tublin, 2014). HFUS evaluations demonstrated that
B. henselae infected mice and B. henselae/B. fragilis 1PSA co-
infected mice showed the most severe morpho-structural signs
of liver disease. These results suggest that damages induced by
B. henselae can be reduced, on the HFUS point of view, by
the colonization with B. fragilis, but not by B. fragilis 1PSA,
supporting the ultrastructural data previous reported (Pagliuca
et al., 2012).
Interestingly, to date there is no standardized scoring/grading
system for liver fibrosis and/or inflammation observed in mice
Frontiers in Microbiology | www.frontiersin.org 7 November 2016 | Volume 7 | Article 1750
fmicb-07-01750 November 4, 2016 Time: 16:43 # 8
Pagliuca et al. Liver Damage Induced by Bartonella
FIGURE 7 | Transmission Electron Microscopy (TEM) micrographs of liver of SCID mice. (A) PBS control group. (B) Mice infected with B. fragilis wild type.
(C) Mice infected with B. fragilis 1PSA. (D) mice infected with B. henselae. (E) co-infected mice with B. henselae/B. fragilis wild type. (F,G) Co-infected mice with
B. henselae/B. fragilis 1PSA. (A) Portal triad with a small bile duct (db) and the portal vein (v). Hepatocytes with rounded nucleus and massive presence of
mitochondria and peroxisomes; (B) portal triad with bile duct (db) and the portal vein (v). Slight amount of collagen (c) and histiocytic cells (h), fibroblasts (f); (C) portal
vein (v) with massive presence of collagen (c) below the endothelium; (D) macro-area rich in collagen (c) and stellate cells (s); (E) portal vein (v) with slight amount of
collagen under the endothelium and histiocytic cell (h); (F) portal vein (v) with considerable amount of collagen below the endothelium and fibroblast (f); (G) altered
endothelial cell with ribbon-mitochondria (m).
by HFUS. Some authors evaluated the sensitivity, the specificity,
and the predictive values of liver echogenicity by HFUS compared
with the renal cortex, and the echostructure and the PV diameter
in rat models of chronic hepatic disease (Lessa et al., 2010). In our
study, we included also other HFUS measurements evaluating
the ultrasonographic diagnosis of hepatic fibrosis and cirrhosis
in human as previously reported by Aubé et al. (1999). Indeed,
in humans, the ratio of the caudate and the right hepatic lobe was
used to diagnose cirrhosis more effectively than a measurement of
a single lobe size (Tchelepi et al., 2002). Portal vein diameter and
velocity were reported as a marker of human portal hypertension
but they could not be used to differentiate the degree of hepatitis
and cirrhosis (Gerstenmaier and Gibson, 2014).
In our study, the quantitative ultrasonographic measurements
did not differ between the infected and the PBS control group.
On the other hand, the qualitative scoring system applied allowed
to find significant differences between the different types of
infections. It should be considered that both the quantitative
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FIGURE 8 | Evaluation of bacteria in SCID mice liver by TEM micrographs. (A,B) Mice infected with B. henselae, (C) co-infected mice with B. henselae/B.
fragilis wild type, (D) co-infected mice with B. henselae/B. fragilis 1PSA. (A) B. henselae (b) within area rich in collagen; (B) B. henselae (b) inside space of Disse;
(C) B. henselae (b) inside space of Disse; (D) B. henselae (b) between the fibers of collagen in space of Disse.
and qualitative applied in our study have been extrapolated from
numerous pre-clinical and clinical reports (Aubé et al., 1999;
Mathiesen et al., 2002; Lu et al., 2003; Bonekamp et al., 2009; Lessa
et al., 2010; Resende et al., 2011; Chen et al., 2013). Since this is the
first application in a murine model of bacterial infection, the lack
of significance might be more related to the need of a diversified
diagnostic approach between different species than to the absence
of pathologic ultrasonographic features.
Various reports have evaluated the sensitivity and specificity
of non-invasive diagnostic aids (Lu et al., 2003; Bonekamp
et al., 2009) but the diagnosis of liver fibrosis still depends
on pathological examination of liver puncture tissue. Different
studies in humans and experimental rodents model tried to
correlate the degree of steatosis, fibrosis, altered liver enzymes
levels, and ultrasonographics findings, achieving quite similar
results (Mathiesen et al., 2002; Guimond et al., 2007; Yan et al.,
2007). Recently, transient and real-time elastography are being
used to assess more objectively and accurately tissue elasticity
but they showed to be reliable only for extensive fibrosis or
cirrhosis (Bonekamp et al., 2009; Gerstenmaier and Gibson, 2014;
Heller and Tublin, 2014). Most pre-clinical studies focused on
steato-fibrosis have used cirrhosis models induced with different
chemicals and/or bile duct ligation, or with genetically engineered
(Lee et al., 2005; Guimond et al., 2007; Yan et al., 2007; Lessa et al.,
2010; Hayashi and Sakai, 2011; Chen et al., 2013).
Our results showed a substantial relationship between
the ultrasonographic and histological findings, confirmed by
the statistical correlation amongst the scores assigned by
the two techniques. Many scientific reports tried to explore
whether a correlation exists between ultrasonographic and
histopathological indexes, but the results vary and sometimes
contradict (Aubé et al., 1999; Mathiesen et al., 2002; Bonekamp
et al., 2009; Lessa et al., 2010), especially considering that different
histological grading/staging approaches for hepatitis exist (Ishak
et al., 1995; Theise, 2007; Bonekamp et al., 2009). Nevertheless,
the two techniques should still be considered as complementary:
the ultrasound examination cannot detect signs of ultrastructural
liver disease caused by B. henselae, whereas it is ideal to identify
the presence of ascites, the dilatation of the hepatic veins and
portal vessels, and to evaluate the liver surface or the presence
of nodularity caused by infective agents.
To the best of our knowledge, this is the first attempt of
studying the hepatic alterations caused by bacterial infection and
the consequent inflammation and fibrosis with HFUS. In fact,
both healing and fibrotic processes, in response to inflammation,
lead to deposition of extracellular matrix and hence to fibrosis
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(Hayashi and Sakai, 2011). Imaging methodologies, including
ultrasonography, play an important role in the detection,
characterization, and management of infectious liver diseases in
human clinical practice. Bacterial abscesses and parasitic, fungal
and viral diseases have more or less specific imaging findings that
together with appropriate clinical information may provide the
most likely diagnosis.
In human beings, B. henselae hepatitis shows non-specific
ultrasonographic signs, i.e., round hypoechoic lesions (Mortelé
et al., 2004). In our model of infection in SCID mice
infected with B. henselae, we were able to detect a series of
ultrasonographic features linked to the inflammatory/fibrotic
response. In addition, ultrasonographic features of co-infected
mice both with B. henseale/B. fragilis and B. henselae/B. fragilis
1PSA, in accordance with histopathological analysis, have
confirmed that inflammatory liver damage caused by B. henselae
can be prevented by B. fragilis colonization (Pagliuca et al.,
2012). In B. henselae infected mice and co-infected mice with
B. fragilis1PSA mutant we also documented a increased presence
of septal fibrosis with numerous marked fibrous septa completely
recapitulate by the co-infection with B. fragilis wild type. This
finding corroborates the hypothesis that PSA is involved in the
process of immunoregulation and exert a protective effect in
murine host (Mazmanian et al., 2005, 2008; Pagliuca et al., 2012).
It is noteworthy that the absence of dead mice and
ultrastructural data showed that SCID mice tolerated B. henselae
infection at high concentrations in agreement with Chiaraviglio
et al. (2010). This tolerance was in contrast with other Gram-
negative bacteremia where without a rapid antibiotic therapy the
death followed quickly the infection (Barquero-Calvo et al., 2007;
Andonegui et al., 2009; Roger et al., 2009). SCID mice, lacking of
mature lymphocytes, do not respond to B. henselae infection with
the formation of granulomas as observed in immunocompetent
mice (Pagliuca et al., 2012) but with a considerable deposition
of collagen in the region surrounding the centrilobular vein and
mostly in the portal region of the liver, a characteristic found
also in human diseases such as BP and BA (Cockerell et al.,
1991; Borczuk et al., 1998). The deposition of collagen would
seem to be due not only to portal fibroblasts but also to the
massive presence of active hepatic stellate cells that lost their
characteristic cytoplasmic drops containing retinoids (Friedman
et al., 1985). Indeed, these cells presented on their membrane Toll
like receptor-2 (TLR-2) and TLR-4 receptors, which are able to
recognize and respond to various pathogen associated molecular
patterns (Brun et al., 2005), including PSA (Surana and Kasper,
2012).
The mice infected with B. fragilis wild type had only a mild
inflammation while those infected with B. fragilis 1PSA had
a minimal presence of collagen around the main vessels that
might be considered physiological. In liver samples of animals
co-infected with B. henselae/B. fragilis wild type a reduction of
collagen and a higher histiocytic response was observed with
respect to the mice co-infected with B. henselae/B. fragilis1PSA.
The increase of histiocytic response was also observed in the
liver of immunocompetent mice infected with B. henselae or
co-infected with B. fragilis wild type (Pagliuca et al., 2012).
This further observation supports the hypothesis that, in
immunocompromised condition, the PSA, recognized by TLR-
2, stimulates the proliferation and activation of innate immunity
cells. Instead in case of co-infections, determines restraints
fibrosis, caused by B. henselae, through production of the anti-
inflammatory cytokine IL-10 (Cohen-Poradosu et al., 2011). The
alterations found in endothelial cells of samples co-infected with
B. henselae/B. fragilis 1PSA could be due, as it is well known, to
the ability of B. henselae to internalize endothelial cells (Dehio
et al., 1997; Salvatore et al., 2008).
CONCLUSION
These data corroborate the hypothesis that liver injury induced
by B. henselae infection can be reduced by B. fragilis PSA in
an immunocompromised murine model. Interestingly, in this
study it was established, for the first time, that the HFUS,
in combination with histopathological evaluation, could be
considered good imaging approach to evaluate hepatic alterations
in experimental murine model.
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